Published in Obesity and Diabetes Week, March 22nd, 2004
The signing of the distribution agreement grants HEE Corp. worldwide exclusivity for this new procedure. Sandy Winick, president, HEE Corp., said they expect to start licensing the treatments once the first group of patients has successfully received the treatment, which will be administered at a United States university or medical institution. The treatment could be available by the summer of 2004.
HEE Corp. has been engaged in the discovery and development of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week